Mineralocorticoid receptor antagonists improve outcomes in patients younger than 75 with CHF and reduced EF

Mineralocorticoid receptor antagonists improve outcomes in patients younger than 75 with CHF and reduced EF is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central